NGM Biopharmaceuticals, Inc   Report issue

For profit Phase 1 Phase 2
Founded: South San Francisco CA United States (2007)

Organization Overview

First Clinical Trial
2013
NCT01776528
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

NGM Biopharmaceuticals | NGM Biopharmaceuticals Australia Pty Ltd | NGM Biopharmaceuticals, Inc